Advanced Asset Management Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Advanced Asset Management Advisors's BMY Position: Q2 2024 in Review
Advanced Asset Management Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 94,800 shares — an estimated $5.14M sold.
Advanced Asset Management Advisors first reported a position in BMY in Q4 2017 and held it in 25 quarters. The position peaked at $7.3M in Q2 2022. 2,153 funds tracked by Wall St. Rank hold BMY as of Q2 2024.
- Advanced Asset Management Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
- Advanced Asset Management Advisors sold 94,800 Bristol-Myers Squibb shares in Q2 2024, an estimated $5.14M.
- Advanced Asset Management Advisors first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 25 quarters.
- Advanced Asset Management Advisors's Bristol-Myers Squibb position peaked at $7.3M in Q2 2022.
- 2,153 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.
Based on Advanced Asset Management Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.